PMID- 18595739 OWN - NLM STAT- MEDLINE DCOM- 20081208 LR - 20161124 IS - 1095-9572 (Electronic) IS - 1053-8119 (Linking) VI - 42 IP - 2 DP - 2008 Aug 15 TI - Kinetic analyses of [123I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: a critical evaluation of the single-scan approach. PG - 548-58 LID - 10.1016/j.neuroimage.2008.05.023 [doi] AB - BACKGROUND: Dopamine-D2 receptor imaging with single-photon emission computed tomography (SPECT) and [(123)I]IBZM is of great interest for basic and applied neurosciences. However, the use of kinetic analyses for quantification of dynamic [(123)I]IBZM SPECT and the validity of the commonly employed single-scan pseudo-equilibrium analysis (PsEA) have not been appropriately investigated. The present study addresses these shortcomings. METHODS: Ten movement disorder patients underwent dynamic SPECT (142 min) after single-bolus [(123)I]IBZM injection. Kinetic analyses comprise: simplified reference tissue model (SRTM), multi-linear reference tissue model (MRTM), their two-parameter versions (SRTM2/MRTM2) and non-invasive graphical analysis (NIGA). Simplified single-scan analyses were performed at peak time of specific binding (peak-equilibrium analysis, PEA) and during pseudo-equilibrium (PsEA). RESULTS: SRTM and MRTM are compromised by the high noise level of dynamic SPECT. SRTM2 and MRTM2 yielded reliable binding potential estimates that agreed excellently (mean difference=-0.1+/-1.0%, R(2)>0.99). Concordance between SRTM/MRTM and SRTM2/MRTM2 was high in cases in which SRTM/MRTM provided reliable results (SRTM2 or MRTM2 vs. SRTM: 3.7+/-5.0%, R(2)=0.88). NIGA was affected by a negative bias (-9.1+/-6.3%, R(2)=0.75; MRTM2 as reference) or high variability (-1.2+/-7.4%, R(2)=0.71) for analyses without and with inclusion of the k(2)'-term, respectively. PsEA showed a positive bias and low correlation in comparison with SRTM2/MRTM2 (7.6+/-10.8%, R(2)=0.59), which was considerably improved for PEA (-2.7+/-7.6%, R(2)=0.72). MRTM2 provided parametric images with minimal bias suited for voxel-wise statistical analyses. CONCLUSIONS: MRTM2 and SRTM2 can be reliably applied to dynamic [(123)I]IBZM SPECT. PEA is a suitable method for clinical routine, while our results discourage the use of PsEA (current clinical standard). FAU - Meyer, Philipp T AU - Meyer PT AD - Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany. pmeyer@ukaachen.de FAU - Sattler, Bernhard AU - Sattler B FAU - Winz, Oliver H AU - Winz OH FAU - Fundke, Rico AU - Fundke R FAU - Oehlwein, Christian AU - Oehlwein C FAU - Kendziorra, Kai AU - Kendziorra K FAU - Hesse, Swen AU - Hesse S FAU - Schaefer, Wolfgang M AU - Schaefer WM FAU - Sabri, Osama AU - Sabri O LA - eng PT - Journal Article DEP - 20080523 PL - United States TA - Neuroimage JT - NeuroImage JID - 9215515 RN - 0 (Benzamides) RN - 0 (Pyrrolidines) RN - 0 (Radiopharmaceuticals) RN - 0 (Receptors, Dopamine D2) RN - 84226-06-2 (3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) SB - IM MH - Adult MH - Aged MH - Benzamides/*pharmacokinetics MH - Corpus Striatum/diagnostic imaging/*metabolism MH - Female MH - Humans MH - Kinetics MH - Male MH - Metabolic Clearance Rate MH - Middle Aged MH - Movement Disorders/diagnostic imaging/*metabolism MH - Protein Binding MH - Pyrrolidines/*pharmacokinetics MH - Radiopharmaceuticals/pharmacokinetics MH - Receptors, Dopamine D2/*metabolism MH - Tomography, Emission-Computed, Single-Photon/*methods EDAT- 2008/07/04 09:00 MHDA- 2008/12/17 09:00 CRDT- 2008/07/04 09:00 PHST- 2008/02/22 00:00 [received] PHST- 2008/05/06 00:00 [revised] PHST- 2008/05/15 00:00 [accepted] PHST- 2008/07/04 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/07/04 09:00 [entrez] AID - S1053-8119(08)00665-4 [pii] AID - 10.1016/j.neuroimage.2008.05.023 [doi] PST - ppublish SO - Neuroimage. 2008 Aug 15;42(2):548-58. doi: 10.1016/j.neuroimage.2008.05.023. Epub 2008 May 23.